亚太益生菌市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

亚太益生元市场已按类型细分为益生菌、益生元、有机酸和精油等。此外,研究范围涵盖了超过五种人口统计数据。

Asia-Pacific Eubiotics Market

Asia-Pacific Eubiotics Market
Study Period: 2016 - 2026
Base Year: 2021
CAGR: 5.8 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

2019 年亚太饲料益生菌市场价值 8.852 亿美元,预计在预测期内的复合年增长率为 7.4%。本地和全球参与者开发研究计划是推动市场增长的主要因素。Provita Eurotech Ltd、Life Products, Inc.、Calpis Co. Ltd、Chr. Hansen A/S 和 Lallemand, Inc. 是市场上的一些主要参与者。研究表明,益生菌比 AGP(阿维拉霉素)和其他 AGP 替代品(如植物化学物质,如精油。因此,提高对益生菌营养益处的认识可能会在预测期内进一步推动益生菌市场。

Scope of the report

Feed Eubiotics are considered to be the commercially-manufactured feed additive products that are used to enhance the characteristics such as weight gain, feed conversion ratio, and feed intake when fed in appropriate proportions. The feed Eubiotics that is accounted for in the commercial compound feed production has only been considered in the scope of the study.​

Type
Probiotics
Lactobacilli
Bifidobacteria
Other Probiotics
Prebiotics
Inulin
Fructo-Oligosaccharides
Galacto-Oligosaccharides
Other Prebiotics
Organic Acids
Essential Oils
Geography
Asia-Pacific
China
India
Indonesia
Thailand
Japan
South Korea
Australia
Rest of Asia-Pacific

Report scope can be customized per your requirements. Click here.

主要市场趋势

酵母衍生益生菌补充剂推动益生菌市场增长

酵母益生菌成分补充剂已成为改善肠道菌群稳定、肠道完整性和自然防御调节等各个层面肠道功能的关键领域。正在进行的田间试验还强调了酵母益生菌对牛和猪的泌乳期的积极影响,以及畜牧业治疗成本降低的证据。截至 2020 年 3 月,针对牛呼吸道疾病 (BRD ) 进行了田间试验)。对抗生素的禁令促进了治疗这种 BRD 的替代研究方法。以每头每天 5 克的剂量率,总共 120 头牛饲养场使用Actisaf Sc 47 和 Safmannan(一种由 Phileo Lesaffre Animal Care 开发的酵母益生菌溶液)处理. 试验结果表明,体重提高了 1.5%,从疾病中恢复过来,治疗成本显着降低了 53.4%。Lallemand 在 2020 年 2 月进行的另一项田间试验提到,用益生菌酵母S. c. 处理后高产母猪的性能得到改善。boulardii.​因此,创新这种新颖的解决方案以提高牛的性能可以被视为寻找抗生素的可持续替代品以在未来几年改善动物性能的潜在机会。​​​

Asia-Pacific Eubiotics Market: Reduction of Treatment Costs, Probiotic Yeast(Actisaf Sc 47 and Safmannan), 2020​

中国将主导益生菌市场

中国是全球饲料益生菌行业的主要参与者之一,在亚太益生菌市场贡献了约 50.80% 的收入份额。益生菌的生产,尤其是用于水产养殖业的益生菌是中国蓬勃发展的行业。乳酸杆菌是中国水产饲料行业最常见的益生菌变种。由于中国爆发非洲猪瘟 (ASF),2018 年生猪存栏量大幅减少。猪群补充缓慢,尤其是在受猪瘟影响的地区,导致近期时间短缺并导致中国猪饲料减少. 上述趋势生动地表明,中国益生菌行业的深刻特征是大力研发投资,重点是产品和区域扩张。而且,

Asia-Pacific Eubiotics Market: Revenue Share in %, China, 2020

竞争格局

所研究的市场高度分散,由 Chr 主导。Hansen A/S、DuPont de Nemours Inc.、Koninklijke DSM NV 和 Bluestar Adisseo Company。DuPont de Nemours Inc. 和 Chr. 作为市场领导者,Hansen A/S 迎合更广泛的产品供应,并拥有强大的地域影响力,从而在市场上提供竞争优势。创收的持续增长进一步促进了市场的增长。市场领导者,例如 Chr。Hansen 正在提供更广泛的饲料益生菌,包括 BIOPLUS® YC、GALLIPRO®、GALLIPRO® Tect 和 BOVAMINE® Dairy,以满足包括猪、家禽和乳制品行业在内的大量动物的需求。此外,该公司在 2018 年占据了健康与营养板块 22% 的份额。​

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions & Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

    3. 4.3 Market Restraints

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Powers of Buyers

      2. 4.4.2 Bargaining Powers of Suppliers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitutes

      5. 4.4.5 Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 Type

      1. 5.1.1 Probiotics

        1. 5.1.1.1 Lactobacilli

        2. 5.1.1.2 Bifidobacteria

        3. 5.1.1.3 Other Probiotics

      2. 5.1.2 Prebiotics

        1. 5.1.2.1 Inulin

        2. 5.1.2.2 Fructo-Oligosaccharides

        3. 5.1.2.3 Galacto-Oligosaccharides

        4. 5.1.2.4 Other Prebiotics

      3. 5.1.3 Organic Acids

      4. 5.1.4 Essential Oils

    2. 5.2 Geography

      1. 5.2.1 Asia-Pacific

        1. 5.2.1.1 China

        2. 5.2.1.2 India

        3. 5.2.1.3 Indonesia

        4. 5.2.1.4 Thailand

        5. 5.2.1.5 Japan

        6. 5.2.1.6 South Korea

        7. 5.2.1.7 Australia

        8. 5.2.1.8 Rest of Asia-Pacific

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Most Adopted Strategies

    2. 6.2 Market Share Analysis

    3. 6.3 Company Profiles

      1. 6.3.1 Life Products, Inc

      2. 6.3.2 Calpis Co. Ltd

      3. 6.3.3 Chr. Hansen A/S

      4. 6.3.4 Lallemand, Inc.

      5. 6.3.5 Danisco A/S

      6. 6.3.6 DSM Nutritional Products, Inc.

      7. 6.3.7 Orffa International Holding B.V.

      8. 6.3.8 Novus International, Inc.

      9. 6.3.9 Kemin Industries, Inc.

      10. 6.3.10 Biovet Joint Stock Company

      11. 6.3.11 Biomin Holding GmbH

      12. 6.3.12 Bluestar Adisseo Company

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

  8. 8. IMPACT OF COVID-19

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Asia Pacific Eubiotics Market market is studied from 2016 - 2026.

The Asia Pacific Eubiotics Market is growing at a CAGR of 5.8% over the next 5 years.

DSM Nutritional Products, Inc., Novus International, Inc., Kemin Industries, Bluestar Adisseo Company, Lallemand, Inc. are the major companies operating in Asia Pacific Eubiotics Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!